Conjunctivitis Drug Pipeline Promising Therapies and Future Developments

Conjunctivitis, which is medically termed as inflammation of the membrane that covers the outermost layer of an eye, can be infective, allergic, or irritant-driven.

However, infective conjunctivitis – especially bacterial, is the most commonly observed type among the three. The global bacterial conjunctivitis drugs market is highly uncertain and is foreseen to witness sluggish to declining growth in the near future.

In 2013, the global market for bacterial conjunctivitis drugs recorded a value of US$ 473.3 Mn. The market is currently exhibiting a sluggish growth but is expected to witness a decline during the next few years and the revenues may drop down to US$ 439.8 Mn through to 2024.

PMR estimates CAGR of 2.7% for 2012-2018; however it is likely to dwindle down to -3.73% during the next half of the forecast period i.e. 2018-2024.